Discover 920 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 920
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
for
High-Risk Prostate Cancer
Location: Portland OR, Seattle WA, West Los Angeles CA,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT05593497
Phase2, Recruiting
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
for
Metastatic Prostate Cancer
Location: Portland OR, Seattle WA, Aurora CO, Kansas City MO,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT05011383
Phase2, Recruiting
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
for
Prostate Adenocarcinoma
Location: Portland OR, San Francisco CA, Fresno CA, Milwaukee WI,
Sponsor: Alessa Therapeutics Inc.
Sex: Male
Age: 21+
Code: NCT06257693
Phase1, Recruiting
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Portland OR, Clackamas OR, Vancouver WA, Oregon City OR,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 0+
Code: NCT04242095
Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Portland OR, San Francisco CA, Las Vegas NV,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
for
Juvenile Psoriatic Arthritis
Location: Portland OR, Salt Lake City UT, Loma Linda CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 17
Code: NCT06751238
Phase1, Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
for
Systemic Lupus Erythematosus
Location: Portland OR, Vancouver, Salt Lake City UT,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 17
Code: NCT05835310
Phase3, Recruiting
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
for
Corneal Scar
Location: Portland OR, Loma Linda CA, Minnetonka MN,
Sponsor: Claris Biotherapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06257355
Phase1, Recruiting
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
for
Limbal Stem Cell Deficiency
Location: Portland OR, Loma Linda CA, Minnetonka MN,
Sponsor: Claris Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06452316
Phase1, Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
for
Glaucoma and Ocular Hypertension
Location: Portland OR, Spokane WA, Sacramento CA,
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT04967989
Phase3, Recruiting
Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy
for
Fuchs Endothelial Dystrophy
Location: Portland OR
Sponsor: Michael D. Straiko, MD
Sex: All
Age: 30 - 70+
Code: NCT03813056
Phase2, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Portland OR, Palo Alto CA, Salt Lake City UT,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase3, Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Portland OR, Seattle WA, Gilbert AZ, Dallas TX,
Sponsor: Schrödinger, Inc.
Sex: All
Age: 18+
Code: NCT05544019
Phase1, Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Portland OR, Vancouver WA, Tualatin OR, Gresham OR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07195734
Phase2, Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Portland OR, Vancouver WA, Tualatin OR, Oregon City OR,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase3, Recruiting
Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer
for
Breast Cancer - Infiltrating Ductal Carcinoma,
Location: Portland OR, Tualatin OR, Gresham OR, Vancouver WA
Sponsor: Legacy Health System
Sex: All
Age: 18+
Code: NCT07506876
Phase2, Recruiting
Endoscopic Treatment of Intestinal Fistulas and Perforations